Login / Signup

A Novel Cuprotosis-Related Gene FDX1 Signature for Overall Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.

Wei-Tong ZhangYi-Ming GongChao-Yang ZhangJia-Shan PanTao HuangYong-Xiang Li
Published in: BioMed research international (2022)
FDX1 may play a role in the progression of ccRCC as a tumor suppressor gene. It can be used as a potential prognostic indicator and therapeutic target of ccRCC. However, the cuprotosis regulatory role in the development of ccRCC needs to be further verified.
Keyphrases
  • end stage renal disease
  • genome wide
  • newly diagnosed
  • ejection fraction
  • copy number
  • prognostic factors
  • peritoneal dialysis
  • transcription factor
  • gene expression
  • risk assessment
  • human health